Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice.
Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice.
复制标题
DOI:
10.1053/j.gastro.2012.09.002
复制
发表时间:
2012-12
期刊:
影响因子:
29.4
通讯作者:
Llovet JM
中科院分区:
文献类型:
--
作者:
Villanueva A;Alsinet C;Yanger K;Hoshida Y;Zong Y;Toffanin S;Rodriguez-Carunchio L;Solé M;Thung S;Stanger BZ;Llovet JM
The Notch signaling pathway is activated in leukemia and solid tumors (such as lung cancer), but little is known about its role in liver cancer. The intracellular domain of Notch was conditionally expressed in hepatoblasts and their progeny (hepatocytes and cholangiocytes) in mice, through Cre expression, under the control of an albumin and α-fetoprotein enhancer and promoter (AFP-NICD). We used comparative functional genomics to integrate transcriptome data from AFP-NICD mice and human hepatocellular carcinoma (HCC) samples (n=683). A Notch gene signature was generated using the nearest template prediction method. AFP-NICD mice developed HCC with 100% penetrance when they were 12 months old. Activation of Notch signaling correlated with activation of 3 promoters of insulin-like growth factor 2 (Igf2); these processes appeared to contribute to hepatocarcinogenesis. Comparative functional genomic analysis identified a signature of Notch activation in 30% of HCC samples from patients. These samples had altered expression in Notch pathway genes and activation of IGF signaling, despite a low frequency of mutations in regions of NOTCH1 associated with cancer. Blocking Notch signaling in liver cancer cells with the Notch activation signature using γ-secretase inhibitors or by expressing a dominant negative form of MAML reduced their proliferation in vitro. Notch signaling is activated in human HCC samples and promotes formation of liver tumors in mice. The Notch signature is a biomarker of response to Notch inhibition in vitro.
登录
查看更多内容
影响因子:
11.2
作者:
Hoshida Y;Nijman SM;Kobayashi M;Chan JA;Brunet JP;Chiang DY;Villanueva A;Newell P;Ikeda K;Hashimoto M;Watanabe G;Gabriel S;Friedman SL;Kumada H;Llovet JM;Golub TR
通讯作者:
Golub TR
影响因子:
158.5
作者:
Llovet, Josep M.;Ricci, Sergio;Bruix, Jordi
通讯作者:
Bruix, Jordi
DOI:
10.1056/nejmoa0804525
发表时间:
2008-11-06
期刊:
The New England journal of medicine
影响因子:
--
作者:
Hoshida Y;Villanueva A;Kobayashi M;Peix J;Chiang DY;Camargo A;Gupta S;Moore J;Wrobel MJ;Lerner J;Reich M;Chan JA;Glickman JN;Ikeda K;Hashimoto M;Watanabe G;Daidone MG;Roayaie S;Schwartz M;Thung S;Salvesen HB;Gabriel S;Mazzaferro V;Bruix J;Friedman SL;Kumada H;Llovet JM;Golub TR
通讯作者:
Golub TR
影响因子:
15.9
作者:
Kaposi-Novak, Pal;Lee, Ju-Seog;Thorgeirsson, Snorri S.
通讯作者:
Thorgeirsson, Snorri S.
影响因子:
45.3
作者:
Altekruse, Sean F.;McGlynn, Katherine A.;Reichman, Marsha E.
通讯作者:
Reichman, Marsha E.